Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1CNS 1

Conditions

Neuroblastoma 2Lymphoma 2Skin Neoplasms 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Osteosarcoma 1Myelodysplastic Syndromes 1Multiple Myeloma 1Metabolic Diseases 1Mesothelioma, Malignant 1Mesothelioma 1Melanoma 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Leukemia, Lymphocytic, Chronic, B-Cell 1Immunologic Deficiency Syndromes 1Hepatoblastoma 1Ganglioneuroblastoma 1Anemia, Aplastic 1

Interventions

fludarabine 2Cyclophosphamide 2talazoparib 1sodium thiosulfate 1irinotecan sucrosofate 1fludarabine phosphate 1codrituzumab 1X-Rays 1Whole-Body Irradiation 1Vorinostat 1Vincristine 1Transplantation 1Temozolomide 1Tacrolimus 1Specimen Handling 1Phantoms, Imaging 1Nivolumab 1Mesna 1Melphalan 1Influenza Vaccines 1Honey 1Fluorouracil 1Doxorubicin 1Cisplatin 1Carboplatin 1Bone Density 1Biopsy 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Hepatoblastoma × Influenza Vaccines × Clear all
NCT01804634 2026-03-13

Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Recruiting
60 enrolled
CNSGastrointestinalSarcoma

Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡